Organigram Secures Supply Agreement With Medical Cannabis by Shoppers

January 16, 2020

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has secured a supply agreement with Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc. (“Shoppers”).

This agreement reflects the companies’ shared commitment to offering Canadian consumers access to high quality medical cannabis products.
“We are extremely proud to partner with Shoppers and believe that our complementary approach to the medical cannabis market will offer the full strength of our combined national networks to Canadian patients,” says Tim Emberg, Senior Vice President of Sales and Commercial Operations. “We are pleased that we will now be able to offer medical cannabis patients across the country even greater access to our growing portfolio of high-quality products.”

Under the terms of the agreement, Organigram will provide Shoppers with a wide range of products including dried flower, oils and other future derivative products as they become available. The agreement is for a three-year term subject to renewal for an additional two years.
“Since our inception, patients have been an important priority for our team,” says Greg Engel, CEO, Organigram. “We want patients to feel supported and to know that we are working on developing products, technology and partnerships with their best interests in mind.”

BACK TO TOP

READ MORE

Contact Moncton Post

contact@monctonpost.ca

© 2021 MONCTON POST. ALL RIGHTS RESERVED.
Free reproduction, transmission or redistribution of content without editing. Credit quote is requested.

Development by